MARKET WIRE NEWS

Expected earnings - Inhibitor Therapeutics Inc

Source: US Earnings Reports
Inhibitor Therapeutics Inc (INTI) is expected to report for Q2 2025
Inhibitor Therapeatics Inc

NASDAQ: INTI

INTI Trading

-5.91% G/L:

$0.0875 Last:

500 Volume:

$0.0875 Open:

mwn-alerts Ad 300

INTI Latest News

INTI Stock Data

$9,786,301
75,822,359
15.07%
6
19880%
Biotechnology & Life Sciences
Healthcare
US
Tampa

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App